SeaSpine Holdings Corp. (SPNE) NASDAQ
$9.54 - (-)
Market Cap: -
As of 01/04/23 12:00 AM EST. Market closed.
SeaSpine Holdings Corp. (SPNE)
NASDAQ
$9.54
- (-)
Market Cap: -
As of 01/04/23 12:00 AM EST. Market closed.
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to ... read more
SeaSpine (www.seaspine.com) is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal implants solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine's orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine's spinal implants portfolio consists of an extensive line of products to facilitate spinal fusion in degenerative, minimally invasive surgery (MIS), and complex spinal deformity procedures. Expertise in both orthobiologic sciences and spinal implants product development allows SeaSpine to offer its surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in approximately 30 countries worldwide. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Winge John J. | Vice President, Sales | Jan 01, 2023 | Option Exercise | $8.35 | 2,490 | 20,792 | 90,951 | Jan 03, 2023, 05:25 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jan 01, 2023 | Option Exercise | $8.35 | 3,411 | 28,482 | 131,284 | Jan 03, 2023, 05:24 PM |
Keran Patrick L | SVP, General Counsel | Jan 01, 2023 | Option Exercise | $8.35 | 3,108 | 25,952 | 69,628 | Jan 03, 2023, 05:24 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jan 01, 2023 | Option Exercise | $8.35 | 3,150 | 26,303 | 48,556 | Jan 03, 2023, 05:23 PM |
Benny Paul S. | VP, Treasurer | Jan 01, 2023 | Option Exercise | $8.35 | 425 | 3,549 | 20,950 | Jan 03, 2023, 05:23 PM |
Bostjancic John J. | Chief Financial Officer | Jan 01, 2023 | Option Exercise | $8.35 | 3,281 | 27,396 | 102,563 | Jan 03, 2023, 05:23 PM |
Valentine Keith | Chief Executive Officer | Jan 01, 2023 | Option Exercise | $8.35 | 7,170 | 59,870 | 333,797 | Jan 03, 2023, 05:22 PM |
Maniar Shweta | Director | Dec 29, 2022 | Sale | $8.00 | 3,786 | 30,288 | 23,993 | Dec 30, 2022, 04:29 PM |
Benny Paul S. | VP, Treasurer | Dec 28, 2022 | Option Exercise | $4.92 | 1,320 | 6,494 | 20,334 | Dec 30, 2022, 04:28 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Dec 28, 2022 | Option Exercise | $4.92 | 2,500 | 12,300 | 126,333 | Dec 30, 2022, 04:28 PM |
Standish Beau | President, Enabling Tech | Jul 14, 2022 | Sale | $5.73 | 50,000 | 286,500 | 0 | Jul 15, 2022, 04:25 PM |
Winge John J. | Vice President, Sales | Jun 30, 2022 | Option Exercise | $4.80 | 1,785 | 8,568 | 88,573 | Jul 01, 2022, 05:08 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jun 30, 2022 | Option Exercise | $4.80 | 2,384 | 11,443 | 46,354 | Jul 01, 2022, 05:07 PM |
Benny Paul S. | VP, Treasurer | Jun 30, 2022 | Option Exercise | $4.80 | 1,261 | 6,053 | 19,014 | Jul 01, 2022, 05:07 PM |
Valentine Keith | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $4.80 | 2,385 | 11,448 | 328,784 | Jul 01, 2022, 05:07 PM |
BRADLEY KEITH | Director | Jun 02, 2022 | Option Exercise | $7.77 | 319 | 2,479 | 88,592 | Jun 03, 2022, 05:22 PM |
Gaeta Renee | Director | Mar 14, 2022 | Sale | $12.03 | 2,000 | 24,060 | 20,113 | Mar 15, 2022, 04:06 PM |
BRADLEY KEITH | Director | Mar 02, 2022 | Option Exercise | $13.25 | 37 | 490 | 72,968 | Mar 04, 2022, 05:55 PM |
Gaeta Renee | Director | Feb 14, 2022 | Sale | $12.06 | 2,000 | 24,120 | 22,113 | Feb 16, 2022, 06:31 PM |
Winge John J. | Vice President, Sales | Jan 28, 2022 | Option Exercise | $11.39 | 2,235 | 25,457 | 86,788 | Feb 01, 2022, 07:18 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jan 28, 2022 | Option Exercise | $11.39 | 2,243 | 25,548 | 123,833 | Feb 01, 2022, 07:17 PM |
Keran Patrick L | SVP, General Counsel | Jan 28, 2022 | Option Exercise | $11.39 | 2,113 | 24,067 | 67,456 | Feb 01, 2022, 07:17 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jan 28, 2022 | Option Exercise | $11.39 | 3,067 | 34,933 | 43,970 | Feb 01, 2022, 07:17 PM |
Bostjancic John J. | Chief Financial Officer | Jan 28, 2022 | Option Exercise | $11.39 | 3,628 | 41,323 | 100,269 | Feb 01, 2022, 07:16 PM |
Valentine Keith | Chief Executive Officer | Jan 28, 2022 | Option Exercise | $11.39 | 13,798 | 157,159 | 326,399 | Feb 01, 2022, 07:16 PM |
Gaeta Renee | Director | Jan 10, 2022 | Sale | $12.35 | 2,000 | 24,700 | 24,113 | Jan 10, 2022, 05:23 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jan 01, 2022 | Option Exercise | $13.62 | 4,801 | 65,390 | 119,592 | Jan 04, 2022, 09:22 PM |
Keran Patrick L | SVP, General Counsel | Jan 01, 2022 | Option Exercise | $13.62 | 5,121 | 69,748 | 65,487 | Jan 04, 2022, 09:22 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jan 01, 2022 | Option Exercise | $13.62 | 5,183 | 70,592 | 41,136 | Jan 04, 2022, 09:21 PM |
Bostjancic John J. | Chief Financial Officer | Jan 01, 2022 | Option Exercise | $13.62 | 6,440 | 87,713 | 96,978 | Jan 04, 2022, 09:21 PM |
Winge John J. | Vice President, Sales | Jan 01, 2022 | Option Exercise | $13.62 | 4,083 | 55,610 | 81,807 | Jan 04, 2022, 09:20 PM |
Winge John J. | Vice President, Sales | Dec 31, 2021 | Option Exercise | $11.58 | 521 | 6,033 | 77,910 | Jan 04, 2022, 09:20 PM |
Valentine Keith | Chief Executive Officer | Jan 01, 2022 | Option Exercise | $13.62 | 11,167 | 152,095 | 314,001 | Jan 04, 2022, 09:20 PM |
Valentine Keith | Chief Executive Officer | Dec 31, 2021 | Option Exercise | $8.92 | 1,026 | 9,152 | 305,196 | Jan 04, 2022, 09:20 PM |
BRADLEY KEITH | Director | Dec 02, 2021 | Option Exercise | $13.38 | 37 | 495 | 73,005 | Dec 03, 2021, 04:19 PM |
BRADLEY KEITH | Director | Sep 02, 2021 | Option Exercise | $16.95 | 37 | 627 | 73,042 | Sep 03, 2021, 05:04 PM |
FEKETE MICHAEL | Director | Aug 20, 2021 | Buy | $14.80 | 10,000 | 148,000 | 88,370 | Sep 02, 2021, 04:06 PM |
Standish Beau | President, Enabling Tech | Jul 21, 2021 | Sale | $19.24 | 10,100 | 194,339 | 0 | Jul 23, 2021, 04:33 PM |
Standish Beau | President, Enabling Tech | Jul 16, 2021 | Sale | $19.24 | 8,054 | 154,932 | 10,100 | Jul 19, 2021, 08:15 PM |
Standish Beau | President, Enabling Tech | Jul 15, 2021 | Sale | $18.83 | 18,154 | 341,865 | 18,154 | Jul 19, 2021, 08:15 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jul 02, 2021 | Option Exercise | $20.23 | 4,567 | 92,390 | 37,545 | Jul 02, 2021, 07:08 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jun 30, 2021 | Option Exercise | $8.92 | 2,383 | 21,256 | 28,905 | Jul 02, 2021, 07:08 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jun 30, 2021 | Option Exercise | $8.92 | 2,383 | 21,256 | 112,467 | Jul 02, 2021, 07:08 PM |
Valentine Keith | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $8.92 | 1,356 | 12,096 | 304,170 | Jul 02, 2021, 07:07 PM |
BRADLEY KEITH | Director | Jun 30, 2021 | Option Exercise | $20.51 | 36 | 738 | 73,079 | Jul 02, 2021, 07:06 PM |
BRADLEY KEITH | Director | Jun 03, 2021 | Option Exercise | $20.28 | 382 | 7,747 | 72,323 | Jun 04, 2021, 04:14 PM |
BRADLEY KEITH | Director | Mar 31, 2021 | Option Exercise | $17.40 | 42 | 731 | 63,201 | Apr 01, 2021, 07:21 PM |
Gaeta Renee | Director | Mar 08, 2021 | Sale | $18.28 | 2,920 | 53,378 | 18,533 | Mar 08, 2021, 04:05 PM |
Gaeta Renee | Director | Feb 22, 2021 | Sale | $17.76 | 3,000 | 53,280 | 21,453 | Feb 23, 2021, 04:16 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jan 01, 2021 | Option Exercise | $17.45 | 5,137 | 89,641 | 26,522 | Jan 05, 2021, 04:14 PM |
Keran Patrick L | VP, General Counsel | Jan 01, 2021 | Option Exercise | $17.45 | 11,308 | 197,325 | 68,127 | Jan 05, 2021, 04:14 PM |
Bostjancic John J. | Chief Financial Officer | Jan 01, 2021 | Option Exercise | $17.45 | 12,851 | 224,250 | 92,497 | Jan 05, 2021, 04:14 PM |
Valentine Keith | Chief Executive Officer | Jan 01, 2021 | Option Exercise | $17.45 | 25,450 | 444,103 | 302,814 | Jan 05, 2021, 04:13 PM |
Valentine Keith | Chief Executive Officer | Dec 31, 2020 | Option Exercise | $8.92 | 1,058 | 9,437 | 280,865 | Jan 05, 2021, 04:13 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jan 01, 2021 | Option Exercise | $17.45 | 11,349 | 198,040 | 110,084 | Jan 05, 2021, 12:00 AM |
Winge John J. | Vice President, Sales | Jan 01, 2021 | Option Exercise | $17.45 | 9,090 | 158,621 | 77,389 | Jan 05, 2021, 12:00 AM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Dec 31, 2020 | Option Exercise | $8.92 | 1,134 | 10,115 | 96,956 | Jan 05, 2021, 12:00 AM |
BRADLEY KEITH | Director | Dec 31, 2020 | Option Exercise | $17.45 | 42 | 733 | 62,310 | Jan 04, 2021, 04:07 PM |
BRADLEY KEITH | Director | Sep 30, 2020 | Option Exercise | $14.30 | 52 | 744 | 61,421 | Oct 02, 2020, 04:07 PM |
HENNEMAN JOHN B III | Director | Aug 05, 2020 | Sale | $15.00 | 10,000 | 150,000 | 60,458 | Aug 05, 2020, 07:39 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jul 02, 2020 | Option Exercise | $10.44 | 4,567 | 47,679 | 22,886 | Jul 06, 2020, 04:06 PM |
Winge John J. | Vice President, Sales | Jun 30, 2020 | Option Exercise | $8.90 | 1,265 | 11,258 | 67,540 | Jul 02, 2020, 04:12 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jun 30, 2020 | Option Exercise | $8.90 | 1,133 | 10,084 | 95,822 | Jul 02, 2020, 04:11 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jun 30, 2020 | Option Exercise | $8.90 | 2,162 | 19,242 | 14,247 | Jul 02, 2020, 04:10 PM |
Valentine Keith | Chief Executive Officer | Jun 30, 2020 | Option Exercise | $8.90 | 1,202 | 10,698 | 279,807 | Jul 02, 2020, 04:09 PM |
BRADLEY KEITH | Director | May 29, 2020 | Option Exercise | $10.65 | 380 | 4,047 | 51,849 | Jun 02, 2020, 04:40 PM |
CARUSO RICHARD E | 10% Owner | Apr 29, 2020 | Sale | $10.56 | 4,921 | 51,959 | 15,457 | May 01, 2020, 05:36 PM |
CARUSO RICHARD E | 10% Owner | Apr 29, 2020 | Option Exercise | $9.43 | 4,921 | 46,405 | 20,378 | May 01, 2020, 05:36 PM |
BRADLEY KEITH | Director | Feb 29, 2020 | Option Exercise | $14.13 | 54 | 763 | 52,229 | Mar 02, 2020, 08:37 PM |
Winge John J. | Vice President, Sales | Jan 01, 2020 | Option Exercise | $12.01 | 13,598 | 163,312 | 66,275 | Jan 02, 2020, 09:18 PM |
Winge John J. | Vice President, Sales | Dec 31, 2019 | Option Exercise | $10.21 | 527 | 5,381 | 51,443 | Jan 02, 2020, 09:18 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jan 01, 2020 | Option Exercise | $12.01 | 11,623 | 139,592 | 94,689 | Jan 02, 2020, 09:17 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Dec 31, 2019 | Option Exercise | $10.21 | 958 | 9,781 | 74,625 | Jan 02, 2020, 09:17 PM |
Valentine Keith | Chief Executive Officer | Jan 01, 2020 | Option Exercise | $12.01 | 38,128 | 457,917 | 278,605 | Jan 02, 2020, 09:17 PM |
Valentine Keith | Chief Executive Officer | Dec 31, 2019 | Option Exercise | $10.21 | 593 | 6,055 | 245,578 | Jan 02, 2020, 09:17 PM |
Keran Patrick L | VP, General Counsel | Jan 01, 2020 | Option Exercise | $12.01 | 15,573 | 187,032 | 58,895 | Jan 02, 2020, 09:17 PM |
Bostjancic John J. | Chief Financial Officer | Jan 01, 2020 | Option Exercise | $12.01 | 18,286 | 219,615 | 81,877 | Jan 02, 2020, 09:16 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jan 01, 2020 | Option Exercise | $12.01 | 1,399 | 16,802 | 12,085 | Jan 02, 2020, 09:16 PM |
Valentine Keith | Chief Executive Officer | Dec 13, 2019 | Buy | $11.12 | 20,000 | 222,400 | 244,985 | Dec 13, 2019, 03:51 PM |
BRADLEY KEITH | Director | Nov 29, 2019 | Option Exercise | $13.23 | 54 | 714 | 52,283 | Dec 02, 2019, 07:50 PM |
BRADLEY KEITH | Director | Aug 29, 2019 | Option Exercise | $11.14 | 54 | 602 | 52,337 | Sep 03, 2019, 04:36 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jul 02, 2019 | Option Exercise | $12.79 | 4,567 | 58,412 | 10,063 | Jul 03, 2019, 04:07 PM |
Cirino Dennis | SVP, Global Spinal Systems | Jun 28, 2019 | Option Exercise | $11.26 | 1,424 | 16,038 | 1,424 | Jul 03, 2019, 04:07 PM |
Winge John J. | Vice President, Sales | Jun 28, 2019 | Option Exercise | $11.26 | 1,042 | 11,736 | 50,916 | Jul 02, 2019, 04:34 PM |
Valentine Keith | Chief Executive Officer | Jun 28, 2019 | Option Exercise | $11.26 | 994 | 11,195 | 224,985 | Jul 02, 2019, 04:34 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jun 28, 2019 | Option Exercise | $11.26 | 729 | 8,210 | 73,667 | Jul 02, 2019, 12:00 AM |
BRADLEY KEITH | Director | May 30, 2019 | Option Exercise | $14.01 | 449 | 6,290 | 52,391 | May 31, 2019, 04:14 PM |
CARUSO RICHARD E | 10% Owner | May 06, 2019 | Sale | $15.17 | 5,020 | 76,153 | 15,457 | May 08, 2019, 04:22 PM |
CARUSO RICHARD E | 10% Owner | May 06, 2019 | Option Exercise | $14.15 | 5,020 | 71,033 | 20,477 | May 08, 2019, 04:22 PM |
BRADLEY KEITH | Director | Feb 28, 2019 | Option Exercise | $15.34 | 50 | 767 | 40,858 | Mar 01, 2019, 04:54 PM |
ESSIG STUART | Director | Feb 15, 2019 | Sale | $16.08 | 7,976 | 128,254 | 0 | Feb 15, 2019, 05:51 PM |
ESSIG STUART | Director | Feb 15, 2019 | Sale | $16.08 | 7,976 | 128,254 | 0 | Feb 15, 2019, 05:51 PM |
ESSIG STUART | Director | Feb 14, 2019 | Sale | $16.09 | 9,000 | 144,810 | 7,976 | Feb 15, 2019, 05:51 PM |
ESSIG STUART | Director | Feb 14, 2019 | Sale | $16.09 | 9,000 | 144,810 | 7,976 | Feb 15, 2019, 05:51 PM |
ESSIG STUART | Director | Feb 12, 2019 | Sale | $16.14 | 10,124 | 163,401 | 17,976 | Feb 13, 2019, 06:13 PM |
ESSIG STUART | Director | Feb 11, 2019 | Sale | $16.01 | 4,450 | 71,245 | 28,100 | Feb 13, 2019, 06:13 PM |
ESSIG STUART | Director | Feb 11, 2019 | Sale | $16.01 | 4,450 | 71,245 | 28,100 | Feb 13, 2019, 06:13 PM |
ESSIG STUART | Director | Feb 13, 2019 | Sale | $16.01 | 1,000 | 16,010 | 16,976 | Feb 13, 2019, 06:13 PM |
ESSIG STUART | Director | Feb 13, 2019 | Sale | $16.01 | 1,000 | 16,010 | 16,976 | Feb 13, 2019, 06:13 PM |
ESSIG STUART | Director | Feb 12, 2019 | Sale | $16.14 | 10,124 | 163,401 | 17,976 | Feb 13, 2019, 06:13 PM |
Valentine Keith | Chief Executive Officer | Jan 01, 2019 | Option Exercise | $18.24 | 23,611 | 430,665 | 224,031 | Jan 03, 2019, 12:00 AM |
Keran Patrick L | VP, General Counsel | Jan 01, 2019 | Option Exercise | $18.24 | 9,914 | 180,831 | 43,671 | Jan 03, 2019, 12:00 AM |
Winge John J. | Vice President, Sales | Jan 01, 2019 | Option Exercise | $18.24 | 8,038 | 146,613 | 49,925 | Jan 03, 2019, 12:00 AM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jan 01, 2019 | Option Exercise | $18.24 | 4,661 | 85,017 | 72,973 | Jan 03, 2019, 12:00 AM |
Bostjancic John J. | Chief Financial Officer | Jan 01, 2019 | Option Exercise | $18.24 | 10,144 | 185,027 | 66,694 | Jan 03, 2019, 12:00 AM |
Valentine Keith | Chief Executive Officer | Dec 31, 2018 | Option Exercise | $6.43 | 1,206 | 7,750 | 184,276 | Jan 03, 2019, 12:00 AM |
Keran Patrick L | VP, General Counsel | Dec 31, 2018 | Option Exercise | $6.43 | 1,122 | 7,210 | 26,127 | Jan 03, 2019, 12:00 AM |
Winge John J. | Vice President, Sales | Dec 31, 2018 | Option Exercise | $6.43 | 1,544 | 9,922 | 32,646 | Jan 03, 2019, 12:00 AM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Dec 31, 2018 | Option Exercise | $6.43 | 1,046 | 6,722 | 49,511 | Jan 03, 2019, 12:00 AM |
BRADLEY KEITH | Director | Nov 30, 2018 | Option Exercise | $19.66 | 50 | 983 | 40,908 | Dec 03, 2018, 06:27 PM |
BRADLEY KEITH | Director | Aug 30, 2018 | Option Exercise | $14.87 | 50 | 743 | 40,958 | Aug 31, 2018, 05:46 PM |
HENNEMAN JOHN B III | Director | Aug 29, 2018 | Sale | $14.65 | 3,407 | 49,913 | 54,708 | Aug 29, 2018, 06:03 PM |
HENNEMAN JOHN B III | Director | Aug 28, 2018 | Sale | $14.65 | 2,029 | 29,725 | 58,115 | Aug 29, 2018, 06:03 PM |
HENNEMAN JOHN B III | Director | Aug 27, 2018 | Sale | $14.72 | 4,564 | 67,182 | 60,144 | Aug 29, 2018, 06:03 PM |
ESSIG STUART | Director | Aug 02, 2018 | Option Exercise | $13.60 | 43,496 | 591,546 | 458,425 | Aug 03, 2018, 04:29 PM |
ESSIG STUART | Director | Aug 02, 2018 | Sale | $14.00 | 43,496 | 608,944 | 414,929 | Aug 03, 2018, 04:29 PM |
Keran Patrick L | VP, General Counsel | Jun 29, 2018 | Option Exercise | $6.43 | 2,185 | 14,041 | 25,005 | Jun 29, 2018, 06:17 PM |
Valentine Keith | Chief Executive Officer | Jun 29, 2018 | Option Exercise | $6.43 | 2,101 | 13,501 | 183,070 | Jun 29, 2018, 06:16 PM |
Winge John J. | Vice President, Sales | Jun 29, 2018 | Option Exercise | $6.43 | 1,763 | 11,329 | 31,102 | Jun 29, 2018, 06:16 PM |
Lipschultz Tyler | SVP, Orthobiologics and BD | Jun 29, 2018 | Option Exercise | $6.43 | 2,261 | 14,529 | 48,465 | Jun 29, 2018, 06:15 PM |
BRADLEY KEITH | Director | Jun 14, 2018 | Option Exercise | $14.03 | 171 | 2,399 | 41,008 | Jun 14, 2018, 08:00 PM |
HENNEMAN JOHN B III | Director | Jun 13, 2018 | Option Exercise | $12.44 | 17,398 | 216,431 | 64,708 | Jun 13, 2018, 07:50 PM |
BRADLEY KEITH | Director | May 18, 2018 | Option Exercise | $11.63 | 2,609 | 30,343 | 30,502 | May 21, 2018, 07:06 PM |
BRADLEY KEITH | Director | May 18, 2018 | Sale | $11.96 | 2,609 | 31,204 | 27,893 | May 21, 2018, 07:06 PM |
Bostjancic John J. | Chief Financial Officer | Mar 23, 2018 | Option Exercise | $9.75 | 366 | 3,569 | 48,715 | Apr 02, 2018, 08:31 PM |
Winge John J. | Vice President, Sales | Mar 23, 2018 | Option Exercise | $9.75 | 177 | 1,726 | 29,339 | Apr 02, 2018, 08:30 PM |
BRADLEY KEITH | Director | Mar 14, 2018 | Option Exercise | $9.97 | 171 | 1,705 | 27,893 | Mar 15, 2018, 01:26 PM |
Winge John J. | Vice President, Sales | Jan 01, 2018 | Option Exercise | $10.12 | 5,518 | 55,842 | 29,516 | Jan 03, 2018, 08:10 PM |
Winge John J. | Vice President, Sales | Dec 31, 2017 | Option Exercise | $6.43 | 1,594 | 10,243 | 20,675 | Jan 03, 2018, 08:10 PM |
Valentine Keith | Chief Executive Officer | Dec 31, 2017 | Option Exercise | $6.43 | 1,266 | 8,135 | 145,031 | Jan 03, 2018, 08:10 PM |
Keran Patrick L | VP, General Counsel | Jan 01, 2018 | Option Exercise | $10.12 | 6,613 | 66,924 | 22,820 | Jan 03, 2018, 08:10 PM |
Keran Patrick L | VP, General Counsel | Dec 31, 2017 | Option Exercise | $6.43 | 1,184 | 7,608 | 13,860 | Jan 03, 2018, 08:10 PM |
Baker Brian D. | VP, Global Operations | Jan 01, 2018 | Option Exercise | $10.12 | 5,593 | 56,601 | 22,044 | Jan 03, 2018, 08:09 PM |
Baker Brian D. | VP, Global Operations | Dec 31, 2017 | Option Exercise | $6.43 | 1,563 | 10,044 | 14,844 | Jan 03, 2018, 08:09 PM |
BRADLEY KEITH | Director | Dec 14, 2017 | Option Exercise | $10.01 | 171 | 1,712 | 28,064 | Dec 14, 2017, 06:22 PM |
FEKETE MICHAEL | Director | Nov 08, 2017 | Buy | $10.25 | 560 | 5,740 | 32,304 | Nov 13, 2017, 01:00 PM |
FEKETE MICHAEL | Director | Nov 10, 2017 | Buy | $10.25 | 930 | 9,533 | 33,234 | Nov 13, 2017, 01:00 PM |
BRADLEY KEITH | Director | Sep 14, 2017 | Option Exercise | $10.39 | 171 | 1,777 | 28,235 | Sep 15, 2017, 10:31 AM |
Keran Patrick L | VP, General Counsel | Jun 30, 2017 | Option Exercise | $6.43 | 2,122 | 13,636 | 12,676 | Jul 05, 2017, 03:37 PM |
Valentine Keith | Chief Executive Officer | Jun 30, 2017 | Option Exercise | $6.43 | 2,040 | 13,109 | 143,765 | Jul 05, 2017, 03:35 PM |
Stephenson Kirtley C. | Director | Jun 30, 2017 | Option Exercise | $11.52 | 1,628 | 18,755 | 44,188 | Jul 05, 2017, 01:37 PM |
SULLIVAN JAMES M | Director | Jun 30, 2017 | Option Exercise | $11.52 | 1,086 | 12,511 | 39,205 | Jul 05, 2017, 01:36 PM |
Winge John J. | Vice President, Sales | Jun 30, 2017 | Option Exercise | $6.43 | 1,712 | 11,001 | 19,081 | Jul 05, 2017, 12:00 AM |
Baker Brian D. | VP, Global Operations | Jun 30, 2017 | Option Exercise | $6.43 | 1,743 | 11,201 | 13,281 | Jul 05, 2017, 12:00 AM |
BRADLEY KEITH | Director | Jun 07, 2017 | Option Exercise | $10.00 | 113 | 1,130 | 13,285 | Jun 08, 2017, 02:02 PM |
SULLIVAN JAMES M | Director | Apr 25, 2017 | Option Exercise | $6.92 | 2,609 | 18,054 | 22,998 | Apr 26, 2017, 11:11 AM |
SULLIVAN JAMES M | Director | Mar 31, 2017 | Option Exercise | $7.85 | 1,593 | 12,505 | 20,389 | Apr 03, 2017, 02:06 PM |
Stephenson Kirtley C. | Director | Mar 31, 2017 | Option Exercise | $7.85 | 2,389 | 18,754 | 19,878 | Apr 03, 2017, 02:04 PM |
Bostjancic John J. | Chief Financial Officer | Mar 23, 2017 | Option Exercise | $7.34 | 365 | 2,679 | 41,556 | Mar 27, 2017, 03:18 PM |
Bostjancic John J. | Chief Financial Officer | Mar 24, 2017 | Option Exercise | $7.32 | 1,435 | 10,504 | 40,121 | Mar 27, 2017, 03:18 PM |
Winge John J. | Vice President, Sales | Mar 24, 2017 | Option Exercise | $7.32 | 429 | 3,140 | 17,369 | Mar 27, 2017, 02:21 PM |
Winge John J. | Vice President, Sales | Mar 23, 2017 | Option Exercise | $7.34 | 186 | 1,365 | 17,798 | Mar 27, 2017, 02:21 PM |
FEKETE MICHAEL | Director | Mar 15, 2017 | Buy | $6.65 | 5,100 | 33,915 | 15,110 | Mar 16, 2017, 11:41 AM |
Baker Brian D. | VP, Global Operations | Mar 13, 2017 | Sale | $6.66 | 4,100 | 27,306 | 11,538 | Mar 14, 2017, 12:22 PM |
Winge John J. | Vice President, Sales | Mar 13, 2017 | Sale | $6.66 | 3,230 | 21,512 | 17,984 | Mar 14, 2017, 12:20 PM |
Keran Patrick L | VP, General Counsel | Mar 13, 2017 | Sale | $6.66 | 6,315 | 42,058 | 10,554 | Mar 14, 2017, 12:13 PM |
ESSIG STUART | Director | Mar 13, 2017 | Buy | $6.67 | 50,000 | 333,500 | 378,946 | Mar 14, 2017, 12:11 PM |
BRADLEY KEITH | Director | Mar 07, 2017 | Option Exercise | $6.78 | 113 | 766 | 13,398 | Mar 09, 2017, 12:12 PM |
BRADLEY KEITH | Director | Dec 07, 2016 | Option Exercise | $7.31 | 113 | 826 | 13,511 | Mar 09, 2017, 12:10 PM |
BRADLEY KEITH | Director | Sep 07, 2016 | Option Exercise | $10.67 | 113 | 1,206 | 13,624 | Mar 09, 2017, 12:08 PM |
Stephenson Kirtley C. | Director | Dec 31, 2016 | Option Exercise | $7.90 | 2,374 | 18,755 | 17,489 | Jan 04, 2017, 11:25 AM |
Winge John J. | Vice President, Sales | Dec 31, 2016 | Option Exercise | $6.72 | 590 | 3,962 | 11,177 | Jan 04, 2017, 11:22 AM |
SULLIVAN JAMES M | Director | Dec 31, 2016 | Option Exercise | $7.90 | 1,583 | 12,506 | 18,813 | Jan 04, 2017, 11:21 AM |
Valentine Keith | Chief Executive Officer | Dec 31, 2016 | Option Exercise | $6.72 | 270 | 1,813 | 101,687 | Jan 04, 2017, 11:16 AM |
BRADLEY KEITH | Director | Dec 07, 2016 | Option Exercise | $7.31 | 376 | 2,749 | 12,985 | Dec 08, 2016, 03:07 PM |
BRADLEY KEITH | Director | Sep 07, 2016 | Option Exercise | $10.67 | 376 | 4,012 | 13,361 | Nov 22, 2016, 02:14 PM |
Winge John J. | Vice President, Sales | Mar 23, 2016 | Option Exercise | $14.23 | 189 | 2,689 | 10,173 | Nov 22, 2016, 02:13 PM |
Winge John J. | Vice President, Sales | Mar 25, 2016 | Option Exercise | $14.08 | 264 | 3,717 | 9,482 | Nov 22, 2016, 02:13 PM |
Winge John J. | Vice President, Sales | Mar 24, 2016 | Option Exercise | $14.08 | 427 | 6,012 | 9,746 | Nov 22, 2016, 02:13 PM |
Bostjancic John J. | Chief Financial Officer | Jul 01, 2016 | Option Exercise | $11.06 | 2,159 | 23,879 | 22,429 | Nov 22, 2016, 12:54 PM |
Bostjancic John J. | Chief Financial Officer | Mar 25, 2016 | Option Exercise | $14.08 | 1,030 | 14,502 | 19,588 | Nov 22, 2016, 12:54 PM |
Bostjancic John J. | Chief Financial Officer | Mar 24, 2016 | Option Exercise | $14.08 | 1,407 | 19,811 | 20,618 | Nov 22, 2016, 12:54 PM |
Bostjancic John J. | Chief Financial Officer | Mar 23, 2016 | Option Exercise | $14.23 | 373 | 5,308 | 22,025 | Nov 22, 2016, 12:54 PM |
Bostjancic John J. | Chief Financial Officer | Nov 18, 2016 | Buy | $7.02 | 3,900 | 27,378 | 26,329 | Nov 22, 2016, 12:54 PM |
Valentine Keith | Chief Executive Officer | Nov 18, 2016 | Buy | $7.00 | 25,000 | 175,000 | 101,417 | Nov 21, 2016, 06:26 PM |
Winge John J. | Vice President, Sales | Jun 30, 2016 | Option Exercise | $8.91 | 1,105 | 9,846 | 11,467 | Jul 01, 2016, 01:37 PM |
Valentine Keith | Chief Executive Officer | Jun 30, 2016 | Option Exercise | $8.91 | 1,317 | 11,734 | 76,417 | Jul 01, 2016, 01:36 PM |
Baker Brian D. | VP, Global Operations | Jun 30, 2016 | Option Exercise | $8.91 | 1,052 | 9,373 | 5,652 | Jul 01, 2016, 01:34 PM |
Keran Patrick L | General Counsel | Jun 30, 2016 | Option Exercise | $8.91 | 1,370 | 12,207 | 1,370 | Jul 01, 2016, 01:32 PM |
Valentine Keith | Chief Executive Officer | May 23, 2016 | Buy | $10.06 | 5,000 | 50,300 | 75,100 | May 24, 2016, 12:51 PM |
Valentine Keith | Chief Executive Officer | May 20, 2016 | Buy | $10.25 | 5,000 | 51,250 | 70,100 | May 24, 2016, 12:51 PM |
Bostjancic John J. | Chief Financial Officer | May 20, 2016 | Buy | $10.34 | 4,326 | 44,731 | 27,398 | May 23, 2016, 04:53 PM |
Bostjancic John J. | Chief Financial Officer | May 19, 2016 | Buy | $10.16 | 674 | 6,848 | 23,072 | May 23, 2016, 04:53 PM |
Winge John J. | VP, Sales | Aug 18, 2015 | Buy | $15.21 | 5,315 | 80,841 | 10,362 | Sep 09, 2015, 06:31 PM |
Bostjancic John J. | Chief Financial Officer | Sep 02, 2015 | Buy | $14.05 | 2,500 | 35,125 | 22,398 | Sep 04, 2015, 05:03 PM |
Baker Brian D. | VP, Global Operations | Aug 27, 2015 | Buy | $14.96 | 4,600 | 68,816 | 4,600 | Aug 31, 2015, 03:45 PM |
Stephenson Kirtley C. | Director | Aug 19, 2015 | Buy | $15.39 | 9,700 | 149,283 | 9,700 | Aug 21, 2015, 08:48 PM |
ESSIG STUART | Director | Aug 20, 2015 | Buy | $15.38 | 12,225 | 188,021 | 65,100 | Aug 20, 2015, 08:34 PM |
ESSIG STUART | Director | Aug 19, 2015 | Buy | $15.31 | 17,661 | 270,390 | 52,875 | Aug 20, 2015, 08:34 PM |
ESSIG STUART | Director | Aug 18, 2015 | Buy | $15.32 | 35,214 | 539,478 | 35,214 | Aug 20, 2015, 08:34 PM |
Valentine Keith | Chief Executive Officer | Aug 20, 2015 | Buy | $15.38 | 12,225 | 188,021 | 65,100 | Aug 20, 2015, 08:33 PM |
Valentine Keith | Chief Executive Officer | Aug 19, 2015 | Buy | $15.31 | 17,661 | 270,390 | 52,875 | Aug 20, 2015, 08:33 PM |
Valentine Keith | Chief Executive Officer | Aug 18, 2015 | Buy | $15.32 | 35,214 | 539,478 | 35,214 | Aug 20, 2015, 08:33 PM |
Owner | Relationship | Date | Value($) |
Winge John J. | Vice President, Sales | 01/01/2023 | 20,792 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 01/01/2023 | 28,482 |
Keran Patrick L | SVP, General Counsel | 01/01/2023 | 25,952 |
Cirino Dennis | SVP, Global Spinal Systems | 01/01/2023 | 26,303 |
Benny Paul S. | VP, Treasurer | 01/01/2023 | 3,549 |
Bostjancic John J. | Chief Financial Officer | 01/01/2023 | 27,396 |
Valentine Keith | Chief Executive Officer | 01/01/2023 | 59,870 |
Maniar Shweta | Director | 12/29/2022 | 30,288 |
Benny Paul S. | VP, Treasurer | 12/28/2022 | 6,494 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 12/28/2022 | 12,300 |
Standish Beau | President, Enabling Tech | 07/14/2022 | 286,500 |
Winge John J. | Vice President, Sales | 06/30/2022 | 8,568 |
Cirino Dennis | SVP, Global Spinal Systems | 06/30/2022 | 11,443 |
Benny Paul S. | VP, Treasurer | 06/30/2022 | 6,053 |
Valentine Keith | Chief Executive Officer | 06/30/2022 | 11,448 |
BRADLEY KEITH | Director | 06/02/2022 | 2,479 |
Gaeta Renee | Director | 03/14/2022 | 24,060 |
BRADLEY KEITH | Director | 03/02/2022 | 490 |
Gaeta Renee | Director | 02/14/2022 | 24,120 |
Winge John J. | Vice President, Sales | 01/28/2022 | 25,457 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 01/28/2022 | 25,548 |
Keran Patrick L | SVP, General Counsel | 01/28/2022 | 24,067 |
Cirino Dennis | SVP, Global Spinal Systems | 01/28/2022 | 34,933 |
Bostjancic John J. | Chief Financial Officer | 01/28/2022 | 41,323 |
Valentine Keith | Chief Executive Officer | 01/28/2022 | 157,159 |
Gaeta Renee | Director | 01/10/2022 | 24,700 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 01/01/2022 | 65,390 |
Keran Patrick L | SVP, General Counsel | 01/01/2022 | 69,748 |
Cirino Dennis | SVP, Global Spinal Systems | 01/01/2022 | 70,592 |
Bostjancic John J. | Chief Financial Officer | 01/01/2022 | 87,713 |
Winge John J. | Vice President, Sales | 01/01/2022 | 55,610 |
Winge John J. | Vice President, Sales | 12/31/2021 | 6,033 |
Valentine Keith | Chief Executive Officer | 01/01/2022 | 152,095 |
Valentine Keith | Chief Executive Officer | 12/31/2021 | 9,152 |
BRADLEY KEITH | Director | 12/02/2021 | 495 |
BRADLEY KEITH | Director | 09/02/2021 | 627 |
FEKETE MICHAEL | Director | 08/20/2021 | 148,000 |
Standish Beau | President, Enabling Tech | 07/21/2021 | 194,339 |
Standish Beau | President, Enabling Tech | 07/16/2021 | 154,932 |
Standish Beau | President, Enabling Tech | 07/15/2021 | 341,865 |
Cirino Dennis | SVP, Global Spinal Systems | 07/02/2021 | 92,390 |
Cirino Dennis | SVP, Global Spinal Systems | 06/30/2021 | 21,256 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 06/30/2021 | 21,256 |
Valentine Keith | Chief Executive Officer | 06/30/2021 | 12,096 |
BRADLEY KEITH | Director | 06/30/2021 | 738 |
BRADLEY KEITH | Director | 06/03/2021 | 7,747 |
BRADLEY KEITH | Director | 03/31/2021 | 731 |
Gaeta Renee | Director | 03/08/2021 | 53,378 |
Gaeta Renee | Director | 02/22/2021 | 53,280 |
Cirino Dennis | SVP, Global Spinal Systems | 01/01/2021 | 89,641 |
Keran Patrick L | VP, General Counsel | 01/01/2021 | 197,325 |
Bostjancic John J. | Chief Financial Officer | 01/01/2021 | 224,250 |
Valentine Keith | Chief Executive Officer | 01/01/2021 | 444,103 |
Valentine Keith | Chief Executive Officer | 12/31/2020 | 9,437 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 01/01/2021 | 198,040 |
Winge John J. | Vice President, Sales | 01/01/2021 | 158,621 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 12/31/2020 | 10,115 |
BRADLEY KEITH | Director | 12/31/2020 | 733 |
BRADLEY KEITH | Director | 09/30/2020 | 744 |
HENNEMAN JOHN B III | Director | 08/05/2020 | 150,000 |
Cirino Dennis | SVP, Global Spinal Systems | 07/02/2020 | 47,679 |
Winge John J. | Vice President, Sales | 06/30/2020 | 11,258 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 06/30/2020 | 10,084 |
Cirino Dennis | SVP, Global Spinal Systems | 06/30/2020 | 19,242 |
Valentine Keith | Chief Executive Officer | 06/30/2020 | 10,698 |
BRADLEY KEITH | Director | 05/29/2020 | 4,047 |
CARUSO RICHARD E | 10% Owner | 04/29/2020 | 51,959 |
CARUSO RICHARD E | 10% Owner | 04/29/2020 | 46,405 |
BRADLEY KEITH | Director | 02/29/2020 | 763 |
Winge John J. | Vice President, Sales | 01/01/2020 | 163,312 |
Winge John J. | Vice President, Sales | 12/31/2019 | 5,381 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 01/01/2020 | 139,592 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 12/31/2019 | 9,781 |
Valentine Keith | Chief Executive Officer | 01/01/2020 | 457,917 |
Valentine Keith | Chief Executive Officer | 12/31/2019 | 6,055 |
Keran Patrick L | VP, General Counsel | 01/01/2020 | 187,032 |
Bostjancic John J. | Chief Financial Officer | 01/01/2020 | 219,615 |
Cirino Dennis | SVP, Global Spinal Systems | 01/01/2020 | 16,802 |
Valentine Keith | Chief Executive Officer | 12/13/2019 | 222,400 |
BRADLEY KEITH | Director | 11/29/2019 | 714 |
BRADLEY KEITH | Director | 08/29/2019 | 602 |
Cirino Dennis | SVP, Global Spinal Systems | 07/02/2019 | 58,412 |
Cirino Dennis | SVP, Global Spinal Systems | 06/28/2019 | 16,038 |
Winge John J. | Vice President, Sales | 06/28/2019 | 11,736 |
Valentine Keith | Chief Executive Officer | 06/28/2019 | 11,195 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 06/28/2019 | 8,210 |
BRADLEY KEITH | Director | 05/30/2019 | 6,290 |
CARUSO RICHARD E | 10% Owner | 05/06/2019 | 76,153 |
CARUSO RICHARD E | 10% Owner | 05/06/2019 | 71,033 |
BRADLEY KEITH | Director | 02/28/2019 | 767 |
ESSIG STUART | Director | 02/15/2019 | 128,254 |
ESSIG STUART | Director | 02/15/2019 | 128,254 |
ESSIG STUART | Director | 02/14/2019 | 144,810 |
ESSIG STUART | Director | 02/14/2019 | 144,810 |
ESSIG STUART | Director | 02/12/2019 | 163,401 |
ESSIG STUART | Director | 02/11/2019 | 71,245 |
ESSIG STUART | Director | 02/11/2019 | 71,245 |
ESSIG STUART | Director | 02/13/2019 | 16,010 |
ESSIG STUART | Director | 02/13/2019 | 16,010 |
ESSIG STUART | Director | 02/12/2019 | 163,401 |
Valentine Keith | Chief Executive Officer | 01/01/2019 | 430,665 |
Keran Patrick L | VP, General Counsel | 01/01/2019 | 180,831 |
Winge John J. | Vice President, Sales | 01/01/2019 | 146,613 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 01/01/2019 | 85,017 |
Bostjancic John J. | Chief Financial Officer | 01/01/2019 | 185,027 |
Valentine Keith | Chief Executive Officer | 12/31/2018 | 7,750 |
Keran Patrick L | VP, General Counsel | 12/31/2018 | 7,210 |
Winge John J. | Vice President, Sales | 12/31/2018 | 9,922 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 12/31/2018 | 6,722 |
BRADLEY KEITH | Director | 11/30/2018 | 983 |
BRADLEY KEITH | Director | 08/30/2018 | 743 |
HENNEMAN JOHN B III | Director | 08/29/2018 | 49,913 |
HENNEMAN JOHN B III | Director | 08/28/2018 | 29,725 |
HENNEMAN JOHN B III | Director | 08/27/2018 | 67,182 |
ESSIG STUART | Director | 08/02/2018 | 591,546 |
ESSIG STUART | Director | 08/02/2018 | 608,944 |
Keran Patrick L | VP, General Counsel | 06/29/2018 | 14,041 |
Valentine Keith | Chief Executive Officer | 06/29/2018 | 13,501 |
Winge John J. | Vice President, Sales | 06/29/2018 | 11,329 |
Lipschultz Tyler | SVP, Orthobiologics and BD | 06/29/2018 | 14,529 |
BRADLEY KEITH | Director | 06/14/2018 | 2,399 |
HENNEMAN JOHN B III | Director | 06/13/2018 | 216,431 |
BRADLEY KEITH | Director | 05/18/2018 | 30,343 |
BRADLEY KEITH | Director | 05/18/2018 | 31,204 |
Bostjancic John J. | Chief Financial Officer | 03/23/2018 | 3,569 |
Winge John J. | Vice President, Sales | 03/23/2018 | 1,726 |
BRADLEY KEITH | Director | 03/14/2018 | 1,705 |
Winge John J. | Vice President, Sales | 01/01/2018 | 55,842 |
Winge John J. | Vice President, Sales | 12/31/2017 | 10,243 |
Valentine Keith | Chief Executive Officer | 12/31/2017 | 8,135 |
Keran Patrick L | VP, General Counsel | 01/01/2018 | 66,924 |
Keran Patrick L | VP, General Counsel | 12/31/2017 | 7,608 |
Baker Brian D. | VP, Global Operations | 01/01/2018 | 56,601 |
Baker Brian D. | VP, Global Operations | 12/31/2017 | 10,044 |
BRADLEY KEITH | Director | 12/14/2017 | 1,712 |
FEKETE MICHAEL | Director | 11/08/2017 | 5,740 |
FEKETE MICHAEL | Director | 11/10/2017 | 9,533 |
BRADLEY KEITH | Director | 09/14/2017 | 1,777 |
Keran Patrick L | VP, General Counsel | 06/30/2017 | 13,636 |
Valentine Keith | Chief Executive Officer | 06/30/2017 | 13,109 |
Stephenson Kirtley C. | Director | 06/30/2017 | 18,755 |
SULLIVAN JAMES M | Director | 06/30/2017 | 12,511 |
Winge John J. | Vice President, Sales | 06/30/2017 | 11,001 |
Baker Brian D. | VP, Global Operations | 06/30/2017 | 11,201 |
BRADLEY KEITH | Director | 06/07/2017 | 1,130 |
SULLIVAN JAMES M | Director | 04/25/2017 | 18,054 |
SULLIVAN JAMES M | Director | 03/31/2017 | 12,505 |
Stephenson Kirtley C. | Director | 03/31/2017 | 18,754 |
Bostjancic John J. | Chief Financial Officer | 03/23/2017 | 2,679 |
Bostjancic John J. | Chief Financial Officer | 03/24/2017 | 10,504 |
Winge John J. | Vice President, Sales | 03/24/2017 | 3,140 |
Winge John J. | Vice President, Sales | 03/23/2017 | 1,365 |
FEKETE MICHAEL | Director | 03/15/2017 | 33,915 |
Baker Brian D. | VP, Global Operations | 03/13/2017 | 27,306 |
Winge John J. | Vice President, Sales | 03/13/2017 | 21,512 |
Keran Patrick L | VP, General Counsel | 03/13/2017 | 42,058 |
ESSIG STUART | Director | 03/13/2017 | 333,500 |
BRADLEY KEITH | Director | 03/07/2017 | 766 |
BRADLEY KEITH | Director | 12/07/2016 | 826 |
BRADLEY KEITH | Director | 09/07/2016 | 1,206 |
Stephenson Kirtley C. | Director | 12/31/2016 | 18,755 |
Winge John J. | Vice President, Sales | 12/31/2016 | 3,962 |
SULLIVAN JAMES M | Director | 12/31/2016 | 12,506 |
Valentine Keith | Chief Executive Officer | 12/31/2016 | 1,813 |
BRADLEY KEITH | Director | 12/07/2016 | 2,749 |
BRADLEY KEITH | Director | 09/07/2016 | 4,012 |
Winge John J. | Vice President, Sales | 03/23/2016 | 2,689 |
Winge John J. | Vice President, Sales | 03/25/2016 | 3,717 |
Winge John J. | Vice President, Sales | 03/24/2016 | 6,012 |
Bostjancic John J. | Chief Financial Officer | 07/01/2016 | 23,879 |
Bostjancic John J. | Chief Financial Officer | 03/25/2016 | 14,502 |
Bostjancic John J. | Chief Financial Officer | 03/24/2016 | 19,811 |
Bostjancic John J. | Chief Financial Officer | 03/23/2016 | 5,308 |
Bostjancic John J. | Chief Financial Officer | 11/18/2016 | 27,378 |
Valentine Keith | Chief Executive Officer | 11/18/2016 | 175,000 |
Winge John J. | Vice President, Sales | 06/30/2016 | 9,846 |
Valentine Keith | Chief Executive Officer | 06/30/2016 | 11,734 |
Baker Brian D. | VP, Global Operations | 06/30/2016 | 9,373 |
Keran Patrick L | General Counsel | 06/30/2016 | 12,207 |
Valentine Keith | Chief Executive Officer | 05/23/2016 | 50,300 |
Valentine Keith | Chief Executive Officer | 05/20/2016 | 51,250 |
Bostjancic John J. | Chief Financial Officer | 05/20/2016 | 44,731 |
Bostjancic John J. | Chief Financial Officer | 05/19/2016 | 6,848 |
Winge John J. | VP, Sales | 08/18/2015 | 80,841 |
Bostjancic John J. | Chief Financial Officer | 09/02/2015 | 35,125 |
Baker Brian D. | VP, Global Operations | 08/27/2015 | 68,816 |
Stephenson Kirtley C. | Director | 08/19/2015 | 149,283 |
ESSIG STUART | Director | 08/20/2015 | 188,021 |
ESSIG STUART | Director | 08/19/2015 | 270,390 |
ESSIG STUART | Director | 08/18/2015 | 539,478 |
Valentine Keith | Chief Executive Officer | 08/20/2015 | 188,021 |
Valentine Keith | Chief Executive Officer | 08/19/2015 | 270,390 |
Valentine Keith | Chief Executive Officer | 08/18/2015 | 539,478 |